Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1998British Journal of Clinical PharmacologyOpen Access

Tamoxifen and risk of idiopathic venous thromboembolism

View Full Paper
Ask AI
Bookmark
Share

Authors

CMChristoph MeierUniversity of BaselHJHershel JickBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meier et al. (1998) studied this question.

synapsesocial.com/papers/6a22902df4540fbb2454223fhttps://doi.org/10.1046/j.1365-2125.1998.00733.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.1991 · 840 citations
  2. 2Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.1989 · 150 citations
  3. 3A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors1989 · 1,480 citations
  4. 4Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies1995 · 510 citations